In the Era of Electronic Health Records and Clinical Genomics

Hagenkord Jill^*
*Correspondence: Hagenkord Jill, Department of Pathology, Creighton University School of Medicine, Omaha, USA, Email:

Description

In the era of Electronic Health Records (EHRs) and clinical genomics, the convergence of these two transformative technologies is reshaping the landscape of healthcare delivery in profound ways. Electronic health records serve as comprehensive digital repositories, capturing and organizing patients' medical information, including clinical notes, laboratory results, and imaging reports. This digitalization of health data not only facilitates seamless communication and collaboration among healthcare providers but also lays the foundation for the integration of genomic information into routine clinical practice. Clinical genomics, propelled by advancements in high-throughput sequencing and bioinformatics, empowers healthcare professionals with unprecedented insights into the genetic basis of health and disease. The integration of genomic data into electronic health records enhances the depth and precision of patient profiles, offering a holistic view that encompasses both clinical and genetic information. This convergence facilitates a more nuanced understanding of an individual's health, enabling personalized and targeted interventions based on their unique genetic makeup [1,2].

In the context of electronic health records, clinical genomics contributes to more accurate diagnoses and tailored treatment strategies. Genetic information can inform medication choices, predict disease risks, and guide preventive measures, offering a level of precision in healthcare decision-making that was once unimaginable. This integration is particularly transformative in the field of oncology, where genomic profiling of tumors is becoming standard practice, guiding the selection of targeted therapies and immunotherapies. Moreover, the combination of EHRs and clinical genomics holds immense potential for advancing population health. Aggregated genomic data within electronic health records allows for the identification of genetic trends, familial predispositions, and rare genetic disorders within specific populations. This knowledge not only informs public health initiatives but also contributes to the development of more effective screening programs and preventive strategies [3].

Despite these promising advancements, challenges persist, ranging from data security and privacy concerns to the need for standardized approaches in interpreting and reporting genomic information. The ethical implications of storing and sharing sensitive genetic data within electronic health records also necessitate careful consideration and robust safeguards to protect patient confidentiality. As healthcare continues to evolve in the digital age, the synergy between electronic health records and clinical genomics represents a paradigm shift towards more personalized, data-driven, and effective healthcare delivery. Interdisciplinary collaboration between healthcare providers, geneticists, informaticians, and policymakers is essential to navigate the complexities of this integration responsibly and ethically. In this era of electronic health records and clinical genomics, the promise of improved patient outcomes, disease prevention, and population health management is within reach, heralding a new era of precision medicine that is both transformative and patient- [4,5].

Furthermore, the integration of electronic health records and clinical genomics not only streamlines patient care but also fosters a continuum of research and innovation. With large-scale data analytics and artificial intelligence tools, researchers can leverage the wealth of information within electronic health records to identify patterns, correlations, and potential breakthroughs in genomics. This interconnected ecosystem supports the discovery of novel genetic associations, the development of more targeted therapies, and the advancement of translational research, ultimately contributing to the evolution of evidence-based medicine. The interoperability of electronic health records becomes particularly crucial in the context of clinical genomics. Seamless data exchange between healthcare systems facilitates the sharing of genetic information, ensuring that a comprehensive understanding of a patient's health is not confined to a single institution. This interoperability enhances collaborative efforts in genomics research, enables second opinions from experts across geographical boundaries, and facilitates the harmonization of genomic data standards, driving a more cohesive and efficient healthcare ecosystem.

Patient engagement is another pivotal aspect of this integrated era. With access to their genomic data within electronic health records, patients become active participants in their healthcare journey. This transparency fosters informed decision-making, empowers individuals to understand their genetic risks, and facilitates more meaningful conversations between patients and healthcare providers about personalized treatment plans, preventive measures, and lifestyle modifications. As this synergistic era progresses, the benefits of electronic health records and clinical genomics extend beyond individual patient encounters. Real-world evidence derived from the amalgamation of clinical and genomic data within electronic health records has the potential to influence health policy, guide resource allocation, and shape public health strategies. This evidence-based approach contributes to more effective healthcare delivery, optimized allocation of resources, and the development of policies that are grounded in the realities of diverse patient populations.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Straiton, Jenny, Tristan Free, Abigail Sawyer and Joseph Martin, et al. "From sanger sequencing to genome databases and beyond." (2019): 60-63.

   Google Scholar, Crossref, Indexed at

2. Ansorge, Wilhelm J. "Next-generation DNA sequencing techniques." N Biotechnol 25 (2009): 195-203.

   Google Scholar, Crossref, Indexed at

3. Levy-Sakin, Michal and Yuval Ebenstein. "Beyond sequencing: Optical mapping of DNA in the age of nanotechnology and nanoscopy." COBIOT 24 (2013): 690-698.

   Google Scholar, Crossref, Indexed at

4. Pareek, Chandra Shekhar, Rafal Smoczynski and Andrzej Tretyn. "Sequencing technologies and genome sequencing." J Appl Genet 52 (2011): 413-435.

   Google Scholar, Crossref, Indexed at

5. Schloss, Jeffery A., Richard A. Gibbs, Vinod B. Makhijani and Andre Marziali, et al. "Cultivating DNA sequencing technology after the human genome project." Annu Rev Genomics Hum Genet 21 (2020): 117-138.

   Google Scholar, Crossref, Indexed at